Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.clinicaltrialsarena.com/news/airway-bronchopulmonary-dysplasia-trial/
https://www.prnewswire.com/news-releases/airway-therapeutics-opens-international-clinical-trial-sites-and-treats-first-patient-in-spain-in-phase-1b-study-of-zelpultide-alfa-at-100-in-preterm-infants-at-risk-for-bronchopulmonary-dysplasia-bpd-301638225.html
https://www.prnewswire.com/news-releases/airway-therapeutics-announces-first-patient-dosed-in-phase-1b-trial-of-at-100-in-preterm-infants-at-risk-for-bronchopulmonary-dysplasia-bpd-301514443.html
https://www.prnewswire.com/news-releases/airway-therapeutics-announces-first-patient-dosed-in-phase-1b-trial-of-at-100-in-severe-covid-19-patients-301363973.html
https://www.biospace.com/article/releases/airway-therapeutics-announces-fda-acceptance-of-ind-for-at-100-s-second-indication-in-severe-covid-19-patients/#:~:text=CINCINNATI%2C%20April%2012%2C%202021%20%2F,Administration%20(FDA)%20has%20accepted%20its
https://www.pharmtech.com/view/fda-accepts-ind-for-airway-therapeutics-treatment-for-severe-covid-19-patients
https://www.pharmaceutical-technology.com/news/fda-airway-therapeutics-ind/